Image credit- washingtonpost.com
Strides Pharma Science Limited (Strides) has announced that its 50:50 JV Strides Vivimed Pte. Ltd, Singapore has received approval for Albendazole Tablets USP 200 mg from the United States Food & Drug Administration (US FDA).
This is the second generic approval by US FDA for Albendazole Tablets.
Albendazole Tablets is a generic version of Albenza Tablets of Amneal Pharmaceuticals, Inc.
According to IQVIA MAT data, the US market for Albendazole Tablets USP 200 mg is approximately US$ 100 Million.
Albendazole is an anthelmintic medication used to treat certain infections caused by tapeworm. Albendazole prevents newly hatched insect larvae (worms) from growing or multiplying in the body.
